04:55 PM EDT, 06/04/2026 (MT Newswires) -- Zhengye Biotechnology ( ZYBT ) said late Thursday it received a written notification letter from Nasdaq on May 29 about non-compliance with the minimum bid price requirement for continued listing.
The company said it has been provided 180 calendar days, or until November 25, to regain compliance with Nasdaq listing rule.